bioRxivImmunology
Rapid recall and de novo T cell responses during SARS-CoV-2 breakthrough infection
M. Koutsakos, A. Reynaldi, W. S. Lee, J. Nguyen, T. Amarasena, G. Taiaroa, P. Kinsella, K. C. Liew, T. Tran, H. E. Kent, H.-X. Tan, L. C. Rowntree, T. H. O. Nguyen, P. Thomas, K. Kedzierska, J. Petersen, J. Rossjohn, D. A. Williamson, D. Khoury, M. P. Davenport, S. J. P. Kent, A. K. Wheatley, J. A. Juno
Abstract
While the protective role of neutralising antibodies against COVID-19 is well-established, questions remain about the relative importance of cellular immunity. Using 6 pMHC-multimers in a cohort with early and frequent sampling we define the phenotype and kinetics of recalled and primary T cell responses following Delta or Omicron breakthrough infection. Recall of spike-specific CD4+ T cells was rapid, with cellular proliferation and extensive activation evident as early as 1 day post-symptom onset. Similarly, spike-specific CD8+ T cells were rapidly activated but showed variable levels of expansion. Strikingly, high levels of SARS-CoV-2-specific CD8+ T cell activation at baseline and peak were strongly correlated with reduced peak SARS-CoV-2 RNA levels in nasal swabs and accelerated clearance of virus. Our study demonstrates rapid and extensive recall of memory T cell populations occurs early after breakthrough infection and suggests that CD8+ T cells contribute to the control of viral replication in breakthrough SARS-CoV-2 infections.
- organism: human
- assay: CITE-seq
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: cell-cell communication
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies
M. M. Painter, T. S. Johnston, … E. J. Wherry·bioRxiv·Feb 5, 2023
- Ex vivo detection of SARS-CoV-2-specific CD8+ T cells: rapid induction, prolonged contraction, and formation of functional memory
I. Schulien, J. Kemming, … C. Neumann-Haefelin·bioRxiv·Aug 13, 2020
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients.
- Robust T and B cell activation is associated with rapid clearance of infectious SARS-CoV-2
Lily Zemelko, Rafael Tiburcio, … Rachel L. Rutishauser·bioRxiv·Nov 5, 2026
- Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
- Vaccine-breakthrough infection by the SARS-CoV-2 Omicron variant elicits broadly cross-reactive immune responses
R. Zhou, K. K.-W. To, … Z. Chen·bioRxiv·Dec 27, 2021